COVID-19 and Technology: A New Age for Clinical Trials

COVID-19 has accelerated the technological and administrative innovation of clinical trials. The RECOVERY trial — responsible for discrediting the hydroxychloroquine treatment and demonstrating the efficacy of the steroid dexamethasone — heralds this paradigm shift. Former FDA Commissioner Robert Califf discusses these developments.